PURPOSE: Most studies on @entity1516 of the tibia (CPT) report on the short-term union rate and refracture rate but do not take into account the long-term outcome. This review includes @entity1 treated with an Ilizarov bone transport, who all reached skeletal maturity. It describes long-term results and highlights any prognostic factors that could predict the final outcome. METHODS: The records of @entity1 with CPT treated with an Ilizarov bone transport in our institution were retrospectively evaluated. RESULTS: A total of 12 consecutive @entity1 were studied. The mean follow-up was 24.5  years (range 6-39  years). Primary consolidation was seen in ten @entity1 (83  %). Half of these @entity1 had a refracture. At final follow-up, eight @entity1 experienced union and four remained un-united, of whom one had an amputation. CONCLUSIONS: The present data confirm a good primary healing rate. However, tibial union at final follow-up was only seen in 67  %, indicating that refracture is the main issue. United bone is often of inferior biological and mechanical quality, so lifetime protection with intramedullary devices, braces or a combination of both is recommended.

Ilizarov bone transport as a treatment of XXXX of the tibia: a long-term follow-up study.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity1516 :: ('MESH:D011542', 'Disease') :: ['congenital pseudarthrosis']
@entity1516 :: (MESH:D011542,Disease) :: ['congenital pseudarthrosis']
